Advertisement
Research ArticleEndocrine and Diabetes

The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat

Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

Article Information

vol. 350 no. 3 657-664
DOI 
https://doi.org/10.1124/jpet.114.213454
PubMed 
24993361
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received January 22, 2014
  • Accepted July 2, 2014
  • Published online July 28, 2014.

Article Versions

Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Henrik H. Hansen,
  2. Jacob Jelsing,
  3. Carl Frederik Hansen,
  4. Gitte Hansen,
  5. Niels Vrang,
  6. Michael Mark,
  7. Thomas Klein, and
  8. Eric Mayoux
  1. Gubra, Hørsholm, Denmark (H.H.H., J.J., C.F.H., G.H., N.V.); and Boehringer Ingelheim Pharma, Biberach, Germany (M.M., T.K., E.M.)
  1. Address correspondence to:
    Dr. Henrik H. Hansen, Gubra Aps Agern Allé 1, DK-2970 Hørsholm, Denmark. E-mail: hbh{at}gubra.dk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2014 to December 2024

AbstractFullPdf
Jul 201434410233
Aug 20144205877
Sep 20141612638
Oct 2014844770
Nov 2014522031
Dec 2014372131
Jan 2015512127
Feb 2015501830
Mar 2015412924
Apr 2015212132
May 2015322130
Jun 2015281929
Jul 2015282024
Aug 2015282228
Sep 2015332441
Oct 2015366552
Nov 2015184737
Dec 2015225540
Jan 2016144839
Feb 2016133941
Mar 2016163475
Apr 2016253750
May 2016373942
Jun 2016293367
Jul 2016265565
Aug 2016233757
Sep 2016226252
Oct 2016912955
Nov 201663533
Dec 2016133731
Jan 2017406425
Feb 2017145620
Mar 2017115028
Apr 201766018
May 2017117249
Jun 2017106630
Jul 2017114514
Aug 2017256218
Sep 2017174630
Oct 2017176036
Nov 2017174836
Dec 2017116415
Jan 2018185017
Feb 2018174925
Mar 2018107949
Apr 2018204421
May 2018182939
Jun 2018172419
Jul 2018162439
Aug 2018162922
Sep 2018153140
Oct 2018173040
Nov 2018202138
Dec 20181911423
Jan 2019112024
Feb 2019171327
Mar 2019171359
Apr 2019201943
May 2019131727
Jun 2019112635
Jul 2019301323
Aug 201975812
Sep 201940319
Oct 20194514
Nov 201960219
Dec 201935919
Jan 20202599
Feb 20201587
Mar 2020131013
Apr 20201269
May 2020131618
Jun 202051110
Jul 2020131812
Aug 20202914
Sep 20203034
Oct 20201813
Nov 20203627
Dec 20205442
Jan 20212541
Feb 20213143
Mar 20213632
Apr 202111757
May 20211621
Jun 20212833
Jul 20212385
Aug 20214463
Sep 20212410
Oct 20212853
Nov 20215751
Dec 202129312
Jan 20226948
Feb 20224426
Mar 20226520
Apr 20223046
May 20222921
Jun 20223421
Jul 20222430
Aug 20221931
Sep 20225103
Oct 20222611
Nov 20224052
Dec 20223512
Jan 20234151
Feb 20233320
Mar 20233122
Apr 20234074
May 202332614
Jun 20232710
Jul 20233337
Aug 20232338
Sep 20235623
Oct 202395111
Nov 202313921
Dec 20236162
Jan 20244243
Feb 20244723
Mar 20248731
Apr 20247155
May 20244723
Jun 20245601
Jul 20244314
Aug 20245331
Sep 20242314
Oct 20244133
Nov 20245974
Dec 20243400

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleEndocrine and Diabetes

Empagliflozin Preserves β-Cell Mass

Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement